Literature DB >> 15176477

Genomic portraits of the nervous system in health and disease.

Velia D'Agata1, Sebastiano Cavallaro.   

Abstract

As the human genome project moves toward its goal of sequencing the entire human genome, gene expression profiling by DNA microarray technology is being employed to rapidly screen genes for biological information. In this review, we will introduce DNA microarray technology, outline the basic experimental paradigms and data analysis methods, and then show with some examples how gene expression profiling can be applied to the study of the central nervous system in health and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176477     DOI: 10.1023/b:nere.0000023607.84480.34

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis.

Authors:  L W Chiang; J M Grenier; L Ettwiller; L P Jenkins; D Ficenec; J Martin; F Jin; P S DiStefano; A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 2.  Gene expression microarrays and the integration of biological knowledge.

Authors:  M O Noordewier; P V Warren
Journal:  Trends Biotechnol       Date:  2001-10       Impact factor: 19.536

3.  Gene expression profiles during long-term memory consolidation.

Authors:  S Cavallaro; B G Schreurs; W Zhao; V D'Agata; D L Alkon
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

4.  Analysis of variance for gene expression microarray data.

Authors:  M K Kerr; M Martin; G A Churchill
Journal:  J Comput Biol       Date:  2000       Impact factor: 1.479

5.  Memory-specific temporal profiles of gene expression in the hippocampus.

Authors:  Sebastiano Cavallaro; Velia D'Agata; Pachiappan Manickam; Franck Dufour; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 6.  DNA microarray technology: devices, systems, and applications.

Authors:  Michael J Heller
Journal:  Annu Rev Biomed Eng       Date:  2002-03-22       Impact factor: 9.590

7.  Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis.

Authors:  C Galli; O Meucci; A Scorziello; T M Werge; P Calissano; G Schettini
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

Review 8.  Neuronal cell death.

Authors:  B Pettmann; C E Henderson
Journal:  Neuron       Date:  1998-04       Impact factor: 17.173

9.  Protein synthesis and memory: a review.

Authors:  H P Davis; L R Squire
Journal:  Psychol Bull       Date:  1984-11       Impact factor: 17.737

10.  Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.

Authors:  S Cavallaro; A Copani; V D'Agata; S Musco; S Petralia; C Ventra; F Stivala; S Travali; P L Canonico
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

View more
  3 in total

1.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

Review 2.  Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.

Authors:  Alejandra Borjabad; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-12       Impact factor: 4.147

Review 3.  Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Andrew I Brooks; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-21       Impact factor: 7.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.